|
NPCE Neuropace Inc 1528287 |
| Balance Sheet |
|
Current Assets
|
$86,978,000.00 |
|
Assets
|
$98,898,000.00 |
|
Current Liabilities
|
$16,168,000.00 |
|
Liabilities
|
$84,444,000.00 |
|
Equity
|
$14,454,000.00 |
|
Shares Out
|
33909408.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-5,900,000.00 |
|
Investing Cash Flow
|
$-117,000.00 |
| Market Analysis |
Market Cap
|
$466,254,360.00 |
|
Price
|
$12.97 |
|
BVPS
|
0.43 |
|
PB
|
31.98 |
|
EPS
|
-0.20 |
|
PS
|
6.20 |
|
FCF
|
$-6,017,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:29 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:25 |
|
| Apr |
May |
Jun |
| 2026-03-03 |
-0.08 |
|
|
2026-05-12 |
-0.20 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-0.26 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-04 |
-0.11 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NPCE documents filed with the SEC.
NPCE Filings
Clear
